Table 3.

12-Week Mean Pairwise Differences between the Placebo Group and Patients Receiving CBGT, Phenelzine, and Combined Treatment

	CBGT			Phenelzine			Combined
	Mean	SE	ES	Mean	SE	ES	Mean	SE	ES
ADIS	−0.26	0.42	0.15	−0.70	0.39	0.42	−1.33**	0.40	0.79
LSAS	−2.28	5.77	0.08	−17.24**	5.52	0.60	−30.19**	5.82	1.05
CGI-Severity	0.08	0.30	0.06	−0.44	0.28	0.32	−0.56	0.30	0.41
HAM-D	0.31	1.24	0.07	0.35	1.20	0.07	−1.30	1.22	0.28
FQ	−2.88	2.14	0.32	−5.21**	1.97	0.58	−8.11**	2.13	0.90
SIAS	−5.20	3.96	0.31	−9.10*	3.61	0.54	−11.56**	3.81	0.68
SPS	−5.67	3.61	0.36	−6.61	3.32	0.42	−12.87**	3.65	0.81
SDS	−0.58	1.69	0. 09	−2.95	1.56	0.43	−4.25**	1.59	0.63

Mean: Mean difference (comparing with Placebo) after controlling for baseline score; SE: Standard Error; ES: Effect size (Cohen’s d). LSAS:Liebowitz Social Anxiety Scale (total score). ADIS: Clinician’s Severity Rating of the Anxiety Disorders Interview Schedule for DSM-IV. CGI-Severity: Clinical Global Impression, Severity Scale. HAM-D: 29-item Hamilton Rating Scale for Depression. FQ: Fear Questionnaire, Social Phobia Subscale. SIAS: Social Interaction Anxiety Scale. SPS: Social Phobia Scale. SDS: Sheehan Disability Scale.

^*p<0.05;

^**p<0.01